Back to search
FDAFDA · Food and drugs·Recall number Z-0291-2027

ALPHENIX INTERVENTIONAL ANGIOGRAPHY SYSTEM REF: INFX-8000V

Published November 4, 2026 · Recall initiated: October 12, 2026

Summary

FDA records medical device Class II recall Z-0291-2027, published November 4, 2026 and initiated October 12, 2026. Recalling firm: Canon Medical System, USA, INC.; Status: Ongoing; Reported quantity: 31 units; Lot: DI-04987670100222/. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Due to software issue, X-ray interventional system may experience internal error if F-Store or imagine acquisition is performed while clinical analysis function is use.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Canon Medical System, USA, INC.
Distributor
US Nationwide distribution in the states of AL, AR, AZ, CA, FL, GA, HI, IL, LA, MA, MI, MN, MS, NC, NV, OH, OR, TX.
Lot
DI-04987670100222/
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was ALPHENIX INTERVENTIONAL ANGIOGRAPHY SYSTEM REF: INFX-8000V recalled?

Yes. FDA published recall Z-0291-2027 on November 4, 2026. Reported hazard: Due to software issue, X-ray interventional system may experience internal error if F-Store or imagine acquisition is performed while clinical analysis function is use.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail